pegaspargase
Showing 1 - 25 of 77
Leukemia Trial in Portland (cyclophosphamide, cytarabine, dexamethasone)
Terminated
- Leukemia
- cyclophosphamide
- +8 more
-
Portland, OregonOHSU Knight Cancer Institute
Dec 13, 2022
Extranodal NK/T-cell Lymphoma Trial in Beijing (Gemcitabine, Pegaspargase, Etoposide)
Recruiting
- Extranodal NK/T-cell Lymphoma
- Gemcitabine
- +3 more
-
Beijing, ChinaBeijing Tongren Hospital
Jun 2, 2021
Extranodal NK/T-cell Lymphoma Trial (Sugemalimab, Placebo, Pegaspargase)
Not yet recruiting
- Extranodal NK/T-cell Lymphoma
- Sugemalimab
- +4 more
- (no location specified)
Jan 17, 2023
Extranodal NK/T-cell Lymphoma, Nasal Type Trial in Guangzhou (Pegaspargase, Anti-PD-1 mAb, Definitive intensity-modulated
Not yet recruiting
- Extranodal NK/T-cell Lymphoma, Nasal Type
- Pegaspargase
- +2 more
-
Guangzhou, Please Select, ChinaSun Yat-sen University Cancer Center
Dec 16, 2020
Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia Trial in Tianjin (Vincristine, Daunorubicin, Cyclophosphamide)
Recruiting
- Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia
- Vincristine
- +9 more
-
Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital
Dec 13, 2022
B-cell Acute Lymphoblastic Leukemia Trial in United States (Inotuzumab ozogamicin, Prednisone Pill, Daunorubicin)
Recruiting
- B-cell Acute Lymphoblastic Leukemia
- Inotuzumab ozogamicin
- +6 more
-
Nashville, Tennessee
- +3 more
Aug 14, 2022
Leukemia Trial (cyclophosphamide, cytarabine, daunorubicin HCl)
Extranodal NK/T-cell Lymphoma Trial (Basiliximab, Pegaspargase)
Unknown status
- Extranodal NK/T-cell Lymphoma
- Basiliximab
- Pegaspargase
- (no location specified)
Apr 6, 2020
Refractory Acute Lymphoblastic Leukemia, Relapsed Acute Lymphoblastic Leukemia Trial in Memphis (drug, biological, radiation)
Not yet recruiting
- Refractory Acute Lymphoblastic Leukemia
- Relapsed Acute Lymphoblastic Leukemia
- Venetoclax
- +16 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Aug 23, 2022
Extranodal NK/T-cell Lymphoma, Nasal Type Trial in Shanghai (Methotrexate, Etoposide, Dexamethasone)
Active, not recruiting
- Extranodal NK/T-cell Lymphoma, Nasal Type
- Methotrexate
- +4 more
-
Shanghai, Shanghai, ChinaRuijin Hospital
Aug 19, 2021
B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Lymphoblastic Lymphoma Trial
Not yet recruiting
- B Acute Lymphoblastic Leukemia
- +5 more
- Biospecimen Collection
- +4 more
- (no location specified)
Oct 28, 2022
Acute Lymphoblastic Leukemia, ALL, Childhood, ALL Trial in Chicago (Ruxolitinib, Cyclophosphamide, Cytarabine)
Recruiting
- Acute Lymphoblastic Leukemia
- +2 more
- Ruxolitinib
- +12 more
-
Chicago, IllinoisUniversity of Chicago Medical Center
Sep 14, 2021
Acute Lymphoblastic Leukemia, Pediatric Trial in Canada, United States (Pegaspargase, Erwinia asparaginase, Cyclophosphamide)
Active, not recruiting
- Acute Lymphoblastic Leukemia, Pediatric
- Pegaspargase
- +14 more
-
Boston, Massachusetts
- +8 more
Nov 10, 2022
Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type, Early-stage, High-Risk Cancer Trial in Beijing (Anti-PD-1 mAb,
Recruiting
- Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type
- +2 more
- Anti-PD-1 monoclonal antibody
- +4 more
-
Beijing, Beijing, ChinaNational Cancer Center/Cancer Hospital, Chinese Academy of Medic
Feb 23, 2022
Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type Trial in Guangzhou (pegaspargase, Gemcitabine, Oxaliplatin)
Recruiting
- Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type
- pegaspargase
- +5 more
-
Guangzhou, Guangdong, ChinaDepartment of Medical Oncology, Sun Yat-sen University Cancer Ce
Mar 12, 2021
Treatment Refusal Trial in Guangzhou (Gemcitabine, etoposide, Pegaspargase)
Unknown status
- Treatment Refusal
- Gemcitabine
- +3 more
-
Guangzhou, Please Select, ChinaSun Yat-sen University Cancer Center
Dec 16, 2020
Recurrent B-Cell Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood B-Lymphoblastic Lymphoma Trial in San Diego,
Completed
- Recurrent B-Cell Childhood Acute Lymphoblastic Leukemia
- Recurrent Childhood B-Lymphoblastic Lymphoma
- dexamethasone
- +18 more
-
San Diego, California
- +2 more
Sep 13, 2022
Drug/Agent Toxicity by Tissue/Organ, Leukemia Trial in Canada, Puerto Rico, United States (asparaginase, cyclophosphamide,
Completed
- Drug/Agent Toxicity by Tissue/Organ
- Leukemia
- asparaginase
- +15 more
-
Boston, Massachusetts
- +9 more
Nov 9, 2022
Acute Lymphoblastic Leukemia Trial in GuangZhou (Cladribine, G-CSF, Cytarabine)
Unknown status
- Acute Lymphoblastic Leukemia
- Cladribine
- +3 more
-
GuangZhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Aug 18, 2019
Acute Lymphoblastic Leukemia, Acute Lymphoblastic Lymphoma Trial in Australia, United States (Prednisone, Vincristine,
Recruiting
- Acute Lymphoblastic Leukemia
- Acute Lymphoblastic Lymphoma
- Prednisone
- +21 more
-
Palo Alto, California
- +6 more
May 2, 2022
Lymphoma Trial in Changsha (pegaspargase, Gemcitabine, Oxaliplatin)
Unknown status
- Lymphoma
- pegaspargase
- +8 more
-
Changsha, Hunan, ChinaHunan Cancer Hospital
Jan 25, 2020
Leukemia, Lymphocytic, Lymphoblastic Lymphoma, T-cell Lymphoma Trial in United States (Palbociclib, Cytarabine, Methotrexate)
Active, not recruiting
- Leukemia, Lymphocytic
- +5 more
- Palbociclib
- +8 more
-
Birmingham, Alabama
- +18 more
Feb 25, 2022
Acute Lymphoblastic Leukemia Trial in Canada, United States (ITMHA, Dexamethasone, Mitoxantrone)
Active, not recruiting
- Acute Lymphoblastic Leukemia
- ITMHA
- +13 more
-
Los Angeles, California
- +17 more
Jun 6, 2022
B Acute Lymphoblastic Leukemia, Ph-Like Acute Lymphoblastic Leukemia Trial in Duarte (Cyclophosphamide, Cytarabine, Daunorubicin
Recruiting
- B Acute Lymphoblastic Leukemia
- Ph-Like Acute Lymphoblastic Leukemia
- Cyclophosphamide
- +8 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jul 26, 2022